Idioma:

Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl‐2 phosphorylation

Abe, Michio ; Yamashita, Jun‐ichi ; Ogawa, Michio

Cancer, 2000-05, Vol.88 (9), p.2000-2009 [Periódico revisado por pares]

New York: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl‐2 phosphorylation
Autor: Abe, Michio ; Yamashita, Jun‐ichi ; Ogawa, Michio
Assuntos: Animals ; Antineoplastic agents ; Antineoplastic Agents, Hormonal - therapeutic use ; apoptosis ; Apoptosis - drug effects ; bcl‐2 ; Biological and medical sciences ; Carcinoma - drug therapy ; Carcinoma - pathology ; Cell Adhesion - drug effects ; Cell Count - drug effects ; Cell Nucleus - drug effects ; Cell Nucleus - ultrastructure ; DNA fragmentation ; DNA Fragmentation - drug effects ; flow cytometry ; G1 Phase - drug effects ; Gene Expression Regulation, Neoplastic - drug effects ; General aspects ; Genes, bcl-2 - drug effects ; Genes, bcl-2 - genetics ; Growth Inhibitors - therapeutic use ; Humans ; Immunoblotting ; Medical sciences ; medroxyprogesterone acetate ; medroxyprogesterone acetate (MPA) ; Medroxyprogesterone Acetate - therapeutic use ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Pancreas ; pancreatic carcinoma ; Pancreatic Neoplasms - drug therapy ; Pancreatic Neoplasms - pathology ; Pharmacology. Drug treatments ; Phosphorylation - drug effects ; Proto-Oncogene Proteins c-bcl-2 - drug effects ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Receptors, Estrogen - analysis ; Receptors, Estrogen - drug effects ; Receptors, Progesterone - analysis ; Receptors, Progesterone - drug effects ; Tumor Cells, Cultured
É parte de: Cancer, 2000-05, Vol.88 (9), p.2000-2009
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Descrição: BACKGROUND A previous study found that medroxyprogesterone acetate (MPA) delayed the in vivo growth of three (AsPC‐1, Capan‐2, and MiaPaCa‐2) of nine human pancreatic carcinoma cell lines transplanted into nude mice (Cancer 1995;75:1263–72). The current study was undertaken to evaluate the basis for this inhibitor. METHODS The estrogen receptor (ER) and progesterone receptor (PgR) status in nine human pancreatic carcinoma cell lines, AsPC‐1, BxPC‐3, Capan‐1, Capan‐2, Hs‐700T, Hs‐766T, MiaPaCa‐2, PANC‐1, and SUIT‐2, was assessed using an enzyme immunoassay (EIA). The authors tested the growth inhibitory activity of MPA and the morphologic changes in these nine pancreatic carcinoma cell lines. Cell cycle progression and DNA fragmentation also were evaluated in these cell lines. Immunoblot analysis was used to determine bcl‐2 expression and phosphorylation. RESULTS In the EIA assay, ER was detected in three cell lines (BxPC‐3, Capan‐2, and MiaPaCa‐2), and PgR was also detected in three (AsPC‐1, Capan‐2, and MiaPaCa‐2). Medroxyprogesterone acetate inhibited the growth of three cell lines (AsPC‐1, Capan‐2, and MiaPaCa‐2) with IC50 values ranging from 2.3 × 10−7 to 6.1 × 10−7 M. In these three responsive cell lines, MPA caused cell detachment and decreased cell density. The nuclei of the MPA‐treated cells were condensed and often fragmented. Cell cycle analysis of these three cell lines showed that MPA induced the appearance of a sub‐G1 peak, which is characteristic of early apoptotic cells. DNA degradation assay after MPA treatment showed a typical DNA ladder pattern consistent with apoptosis. Immunoblot analysis of MPA‐treated cells that overexpressed bcl‐2 revealed a pattern consistent with bcl‐2 phosphorylation. CONCLUSIONS Clinically attainable concentrations of MPA can inhibit the growth of some human pancreatic carcinoma cells in vitro by inducing apoptosis, probably through their PgR, in association with the phosphorylation of bcl‐2. This agent may be useful for treating patients with pancreatic carcinoma. Cancer 2000;88:2000–9. © 2000 American Cancer Society. Clinically attainable concentrations of medroxyprogesterone acetate inhibit the growth of some human pancreatic carcinoma cells in vitro by inducing apoptosis, probably through their progesterone receptor, in association with phosphorylation of bcl‐2, indicating that it may be useful for the treatment of human pancreatic carcinoma.
Editor: New York: John Wiley & Sons, Inc
Idioma: Inglês

Links

Voltar para lista de resultados

Anterior Resultado 2

Realização: Logos de Redes Sociais:

Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl‐2 phosphorylation

Abe, Michio ; Yamashita, Jun‐ichi ; Ogawa, Michio

New York: John Wiley & Sons, Inc

Buscando em bases de dados remotas. Favor aguardar.